BostonSight

Boston Foundation for Sight, d/b/a Bostonsight, is a world renowned nonprofit eye health care organization. Our mission is to improve quality of life by transforming The understanding, treatment, and care of The ocular surface. Since 1992 we have restored Sight to thousands of patients from around The world. Prosthetic replacement of The ocular surface ecosystem (prose) is an integrated and iterative treatment pioneered by Bostonsight that restores visual function, supports healing, reduces symptoms and improves quality of life for patients suffering with ocular surface disease. Bostonsight prose uses fda cleared custom designed and fabricated prosthetic devices to replace or support impaired ocular surface system functions.

Bostonsight's clinical experience in ocular surface disease creates The necessary Foundation for driving research and ultimately innovation in The design and application of scleral lenses for improving quality of life for patients around The world. The organization's prospective clinical research program is unique as we draw from our history of direct patient care, aiming to solve new clinical challenges with direct in-house access to engineering, software design and our state-of-the-art manufacturing facility. In 2018, Bostonsight was named The number one contributor to scleral lens peer-reviewed publications; and in 2021, an analysis in contact lens and anterior eye listed Bostonsight as The most impactful institution in scleral lens publications.